Robert Sikorski Md, Phd

Robert Sikorski Md, Phd Email and Phone Number

Managing Director at Woodside Way Ventures @
Robert Sikorski Md, Phd's Location
South San Francisco, California, United States, United States
Robert Sikorski Md, Phd's Contact Details

Robert Sikorski Md, Phd work email

Robert Sikorski Md, Phd personal email

n/a
About Robert Sikorski Md, Phd

Biotechnology executive with broad leadership and drug development experience in driving pre-IND, early, and late stage programs (involving antibodies, fusion proteins, cell therapies, viruses, and small molecules).Focused on the rapid development of next generation therapies for patients. Accomplished in the acquisition and partnering of assets.Accomplished in investor relations.

Robert Sikorski Md, Phd's Current Company Details
Woodside Way Ventures

Woodside Way Ventures

Managing Director at Woodside Way Ventures
Robert Sikorski Md, Phd Work Experience Details
  • Woodside Way Ventures
    Managing Director
    Woodside Way Ventures Apr 2017 - Present
  • Indapta Therapeutics (Nk Cell Therapy)
    Founding Cmo
    Indapta Therapeutics (Nk Cell Therapy) Dec 2020 - Present
  • Five Prime Therapeutics, Inc. (Acquired By Amgen)
    Senior Vice President, Acting Chief Medical Officer To Chief Medical Officer
    Five Prime Therapeutics, Inc. (Acquired By Amgen) Jan 2016 - Mar 2017
  • Five Prime Therapeutics, Inc. (Acquired By Amgen)
    Vice President, Global Clinical Development
    Five Prime Therapeutics, Inc. (Acquired By Amgen) Sep 2014 - Jan 2016
    * member of the executive committee* lead all therapeutic areas * lead pharmacovigilance and safety* participate in investor relations programs* engaged in pre IND pipeline development* support business development
  • Medimmune (Biologics Research & Development Site For Astrazeneca)
    Senior Director, Global Oncology Clinical Development
    Medimmune (Biologics Research & Development Site For Astrazeneca) Dec 2010 - Sep 2014
    Gaithersburg, Maryland, Us
    * led an early stage clinical development group focused on immunotherapies* development efforts included: OX40 agonists, anti CTLA4, anti PD1, anti PDL1, CEA/CD3-bispecific, TLR 7/8 dual agonist, and an oncolytic vesicular stomatitis virus * preclinical, IND, FIH, Phase I-II* business development and partnering (including deals with academia, large pharmaceutical companies, and small biotechnology companies)* led FDA ODAC
    View
  • Amgen
    Director, Global Oncology Clinical Development
    Amgen Mar 2006 - Dec 2010
    Thousand Oaks, Ca, Us
    * led late stage biologics and small molecule clinical development efforts* biomarker-based phase III study leading to EMA marketing approval* SPA, global phase III (1400+ sub), and postmarketing clinical trials* significant FDA and global regulatory experience* staff manager
    View
  • Genzyme
    Medical Affairs
    Genzyme Jan 2004 - Mar 2006
    Paris, France, Fr
    * external consultant on physician access projects for multiple products
    View
  • Mednav, Inc
    Chief Technology Officer
    Mednav, Inc Nov 1997 - Dec 2003
    * led product development group* commercialized enterprise-level products to capture and visualize biomedical data* business development, partnering, raised private equity

Robert Sikorski Md, Phd Skills

Clinical Development Drug Development Biotechnology Clinical Trials Oncology Life Sciences Drug Discovery Pharmaceutical Industry Ind Translational Medicine Biopharmaceuticals Clinical Research Immunology Fda Cancer Cell Team Leadership Biomarkers New Business Development Lifesciences Medical Affairs Biologics Medicine Pharmacology Laboratory Vaccines Cro Translational Research Genomics Gcp Monoclonal Antibodies Internal Medicine

Robert Sikorski Md, Phd Education Details

  • Howard Hughes Medical Institute Fellowship, National Cancer Institute
    Howard Hughes Medical Institute Fellowship, National Cancer Institute
  • Johns Hopkins Sidney Kimmel Comprehensive Cancer Center
    Johns Hopkins Sidney Kimmel Comprehensive Cancer Center
    Medical Oncology
  • Massachusetts General Hospital
    Massachusetts General Hospital
    Internal Medicine
  • The Johns Hopkins University School Of Medicine
    The Johns Hopkins University School Of Medicine
    Cellular & Molecular Biology
  • The Pennsylvania State University
    The Pennsylvania State University
    Schreyer Honors College

Frequently Asked Questions about Robert Sikorski Md, Phd

What company does Robert Sikorski Md, Phd work for?

Robert Sikorski Md, Phd works for Woodside Way Ventures

What is Robert Sikorski Md, Phd's role at the current company?

Robert Sikorski Md, Phd's current role is Managing Director at Woodside Way Ventures.

What is Robert Sikorski Md, Phd's email address?

Robert Sikorski Md, Phd's email address is me****@****ski.com

What schools did Robert Sikorski Md, Phd attend?

Robert Sikorski Md, Phd attended Howard Hughes Medical Institute Fellowship, National Cancer Institute, Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Massachusetts General Hospital, The Johns Hopkins University School Of Medicine, The Pennsylvania State University.

What are some of Robert Sikorski Md, Phd's interests?

Robert Sikorski Md, Phd has interest in Science And Technology, Children, Health.

What skills is Robert Sikorski Md, Phd known for?

Robert Sikorski Md, Phd has skills like Clinical Development, Drug Development, Biotechnology, Clinical Trials, Oncology, Life Sciences, Drug Discovery, Pharmaceutical Industry, Ind, Translational Medicine, Biopharmaceuticals, Clinical Research.

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant

Download 750 million emails and 100 million phone numbers

Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.